Imbalance of Osteoclastogenesis-Regulating Factors in Patients With Celiac Disease

作者: Anna Taranta , Dario Fortunati , Maurizio Longo , Nadia Rucci , Enzo Iacomino

DOI: 10.1359/JBMR.040319

关键词:

摘要: Celiac disease is an autoimmune disorder characterized by atrophy of the intestine villi triggered ingestion gluten in genetically susceptible individuals. The association between celiac and low BMD has been recognized, but mechanisms disturbance are poorly understood. We show imbalance cytokines relevant to bone metabolism patients' sera direct effect these on vitro cell activity. Introduction: associated with mineral derangement BMD. investigated whether serum factors patients could affect human activity vitro. Materials Methods: studied two groups patients— one a gluten-free diet another before diet— both decreased mass. Patients were for turnover markers, their used culturing cells from healthy donors evaluate changes Results: N-terminal telopeptide procollagen type I interleukin (IL)-6 higher than normal not diet. IL-1 TNF-/ all patients. IL-12 was reduced patients, whereas IL-18 only RANKL/Osteoprotegerin (OPG) ratio increased Persistently osteoclast numbers obtained peripheral blood mono- nuclear incubation versus control In osteoblasts individuals, OPG expression lower when used. Proliferation, alkaline phosphatase, nodule mineralization osteoblast cultures containing either or Conclusions: conclude that loss might also be caused cytokine directly affecting osteoclastogenesis J Bone Miner Res 2004;19:1112-1121. Published online March 22, 2004; doi: 10.1359/JBMR.040319

参考文章(36)
Lawrence G. Raisz, Physiology and Pathophysiology of Bone Remodeling Clinical Chemistry. ,vol. 45, pp. 1353- 1358 ,(1999) , 10.1093/CLINCHEM/45.8.1353
S. L. Teitelbaum, Bone Resorption by Osteoclasts Science. ,vol. 289, pp. 1504- 1508 ,(2000) , 10.1126/SCIENCE.289.5484.1504
VM Salvati, TT MacDonald, M Bajaj-Elliott, M Borrelli, Annamaria Staiano, S Auricchio, R Troncone, G Monteleone, Interleukin 18 and associated markers of T helper cell type 1 activity in coeliac disease Gut. ,vol. 50, pp. 186- 190 ,(2002) , 10.1136/GUT.50.2.186
Atsuko Mizuno, Takeshi Kanno, Masaki Hoshi, Osamu Shibata, Kazuki Yano, Nobuaki Fujise, Masahiko Kinosaki, Kyoji Yamaguchi, Eisuke Tsuda, Akihiko Murakami, Hisataka Yasuda, Kanji Higashio, Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis. Journal of Bone and Mineral Metabolism. ,vol. 20, pp. 337- 344 ,(2002) , 10.1007/S007740200049
Joshua J. Jacobs, Kenneth A. Roebuck, Michael Archibeck, Nadim J. Hallab, Tibor T. Glant, Osteolysis: basic science. Clinical Orthopaedics and Related Research. ,vol. 393, pp. 71- 77 ,(2001) , 10.1097/00003086-200112000-00008
M.L. Bianchi, M.T. Bardella, Bone and celiac disease. Calcified Tissue International. ,vol. 71, pp. 465- 471 ,(2002) , 10.1007/S00223-001-2131-6
N. Yamada, S. Niwa, T. Tsujimura, T. Iwasaki, A. Sugihara, H. Futani, S. Hayashi, H. Okamura, H. Akedo, N. Terada, Interleukin-18 and Interleukin-12 Synergistically Inhibit Osteoclastic Bone-resorbing Activity Bone. ,vol. 30, pp. 901- 908 ,(2002) , 10.1016/S8756-3282(02)00722-6
N J Horwood, N Udagawa, J Elliott, D Grail, H Okamura, M Kurimoto, A R Dunn, T Martin, M T Gillespie, Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. Journal of Clinical Investigation. ,vol. 101, pp. 595- 603 ,(1998) , 10.1172/JCI1333
Gianfranco Caselli, Marco Mantovanini, Carmelo A. Gandolfi, Marcello Allegretti, Simonetta Fiorentino, Luigi Pellegrini, Gabriella Melillo, Riccardo Bertini, Wilma Sabbatini, Roberto Anacardio, Gaetano Clavenna, Giancarlo Sciortino, Anna Teti, Tartronates: A New Generation of Drugs Affecting Bone Metabolism Journal of Bone and Mineral Research. ,vol. 12, pp. 972- 981 ,(1997) , 10.1359/JBMR.1997.12.6.972
G. A. Rodan, Therapeutic Approaches to Bone Diseases Science. ,vol. 289, pp. 1508- 1514 ,(2000) , 10.1126/SCIENCE.289.5484.1508